Gut Clinic, a specialised healthcare platform focused on integrated gastroenterology, liver and metabolic care, has raised $1 million (approximately ₹9 crore) in a seed funding round. The round was backed by a consortium of over 15 strategic investors spanning healthcare and industry leadership.
Notable participants include Dr. Amitoj Singh, a Harvard-trained preventive care specialist from the University of Arizona; Dr. Aman Rajpal of the University of California, San Francisco and a recognised fatty liver expert; Ankur Kathuria of Alpha Wave Global; Juhi Bhatnagar of Forj Capital; and Deepak Garg, Senior Executive Vice President at Reliance Industries.
The capital infusion comes amid rising lifestyle-related digestive and metabolic disorders in India, where an estimated 70 million people are affected. With gastrointestinal diseases on the rise, liver disease among the leading causes of mortality, and fatty liver impacting nearly one in three Indians, the current hospital-centric and reactive care model is increasingly under strain.
Founded by Dr. Akshat Kumar, a US-certified physician and Wharton MBA who previously led McKinsey’s global clinical operations practice, Gut Clinic aims to shift care “upstream” through early diagnosis, protocol-driven treatment and long-term disease management. The outpatient-first model combines specialised centres with day-care and hospital partnerships, supported by technology-enabled clinical systems.
“This funding allows us to strengthen the clinical systems required to deliver consistent, high-quality outpatient care at scale,” said Dr. Kumar. “We aim to complement hospitals by managing chronic and preventive gastro, liver and metabolic conditions more effectively outside acute settings.”
The venture builds on the clinical legacy of Dr. Ajay Kumar, a B.C. Roy Awardee and Chairman of Pan Max, Gastroenterology & Hepatology India. The advisory board includes prominent figures such as Dr. Nageshwar Reddy, Chairman of AIG Hospitals, and internationally renowned pancreatologist Dr. Suresh Chari. The founding leadership team also includes Dr. Manav Wadhawan as Chief Strategy and Medical Officer, bringing expertise in liver and metabolic health.
Currently operating in Delhi NCR, Gut Clinic plans to expand into Chandigarh, Punjab and other parts of Northern India, with a near-to-medium-term target of establishing more than 20 centres. The broader ambition is to build India’s largest integrated gastro-metabolic platform, tapping into a preventive healthcare market estimated at $197 billion and improving long-term patient outcomes through structured, specialist-led outpatient care.
